Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Liu X, Cheng Y, Sheng W, et al. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol. 2010;10:1465–71.
2. Xia R, Zhou Y, Wang Y, Yuan J, Ma X. Hepatoid adenocarcinoma of the stomach: current perspectives and new developments. Front Oncol. 2021;11:633916.
3. Zeng XY, Yin YP, Xiao H, et al. Clinicopathological characteristics and prognosis of hepatoid adenocarcinoma of the stomach: evaluation of a pooled case series. Curr Med Sci. 2018;6:1054–61.
4. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): gastric cancer (Version 2.2021). March 9, 2021. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.
5. Lin JX, Lin JP, Hong QQ, et al. Nomogram to predict recurrence and guide a pragmatic surveillance strategy after resection of hepatoid adenocarcinoma of the stomach: a retrospective multicenter study. Ann Surg Oncol. 2023;30:2942--53. https://doi.org/10.1245/s10434-022-12757-w.